Mabpharm Limited (HKG:2181)
Hong Kong · Delayed Price · Currency is HKD 0.5100
0.00 (0.00%)
Feb 11, 2026, 3:33 PM HKT
Mabpharm Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -27.48 | -127.95 | -209.36 | -210.82 | -291.74 | -184.63 |
Depreciation & Amortization | 60.08 | 61.33 | 60.7 | 51.55 | 43.88 | 24.4 |
Loss (Gain) From Sale of Assets | - | - | - | -0.03 | 0.07 | - |
Loss (Gain) From Sale of Investments | -0.01 | -0.12 | -0.34 | -0.04 | - | - |
Stock-Based Compensation | 11.15 | 11.82 | 13.47 | 9.78 | 12.24 | 12.41 |
Provision & Write-off of Bad Debts | 1.09 | 1.88 | 0.43 | 0.12 | - | - |
Other Operating Activities | 13.55 | 14.08 | 10.79 | 10.57 | 7.05 | 26.41 |
Change in Accounts Receivable | -82.27 | -76.98 | -10.32 | -8.86 | -0.79 | - |
Change in Inventory | -44.08 | -8.97 | -1.24 | -47.59 | -19.79 | -11.23 |
Change in Accounts Payable | 87.98 | 42.89 | -4.43 | 9.76 | 27.19 | -5.51 |
Change in Unearned Revenue | 63.58 | 59.43 | 199.28 | 84.6 | -30.28 | 11.35 |
Change in Other Net Operating Assets | 19.52 | 18.49 | -1.59 | 44.09 | 52.72 | -20.42 |
Operating Cash Flow | 103.11 | -4.1 | 57.39 | -56.89 | -199.47 | -147.23 |
Capital Expenditures | -49.52 | -26.14 | -19.04 | -125.13 | -148.67 | -197.24 |
Sale of Property, Plant & Equipment | - | - | - | 0.04 | 0.04 | - |
Divestitures | 0.12 | 0.12 | 15.39 | - | - | - |
Sale (Purchase) of Intangibles | -61.7 | -33.35 | - | - | - | - |
Investment in Securities | -0.11 | - | - | -15 | - | 179.34 |
Other Investing Activities | 0.54 | -38.83 | 0.15 | 35.13 | -30.79 | 173.9 |
Investing Cash Flow | -110.67 | -98.2 | -3.51 | -104.96 | -179.42 | 156 |
Long-Term Debt Issued | - | 81.11 | 123.07 | 122.33 | - | - |
Total Debt Issued | 110 | 81.11 | 123.07 | 122.33 | - | - |
Short-Term Debt Repaid | - | -49.02 | -2.25 | - | - | -63.09 |
Long-Term Debt Repaid | - | -9.28 | -31.83 | -8.17 | -15.35 | -11.9 |
Total Debt Repaid | -75.09 | -58.31 | -34.08 | -8.17 | -15.35 | -74.99 |
Net Debt Issued (Repaid) | 34.91 | 22.81 | 89 | 114.17 | -15.35 | -74.99 |
Other Financing Activities | -7.28 | -4.53 | -3.4 | -1.9 | -2.43 | -5.49 |
Financing Cash Flow | 27.63 | 18.28 | 85.6 | 112.26 | -17.78 | -80.48 |
Foreign Exchange Rate Adjustments | 0.02 | 0.01 | 0.29 | 1.59 | -6.62 | -32.16 |
Net Cash Flow | 20.1 | -84 | 139.78 | -47.99 | -403.29 | -103.87 |
Free Cash Flow | 53.59 | -30.24 | 38.35 | -182.01 | -348.14 | -344.47 |
Free Cash Flow Margin | 12.64% | -11.71% | 44.00% | -325.50% | -420.04% | - |
Free Cash Flow Per Share | 0.01 | -0.01 | 0.01 | -0.04 | -0.08 | -0.08 |
Cash Interest Paid | 7.28 | 4.53 | 3.4 | 1.9 | 2.43 | 4.21 |
Levered Free Cash Flow | -113 | -151.36 | -77.63 | -245.86 | -331.03 | -179.64 |
Unlevered Free Cash Flow | -106.4 | -144.76 | -71.65 | -241.37 | -329.53 | -177.17 |
Change in Working Capital | 44.73 | 34.85 | 181.71 | 82 | 29.04 | -25.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.